Financing type:  brokered private placement

Gross proceeds:  $4,001,250 (U.S.)

Offering:  970,000 common shares with 970,000 warrants attached

Offering price:  $4.125 (U.S.) per common share

Warrant exercise terms:  $4.64 (U.S.) per common share for a five-year period

Overallotment option:  The company has granted the underwriters a 45-day option to purchase up to 145,500 common shares and/or warrants at the initial public offering price to cover overallotments, if any.

Disclosure:  Refer to the company's news releases dated May 29, 2024, Oct. 28, 2024, Nov. 13, 2024, and Nov. 15, 2024.